[Genetic and immunologic determinants of intravesical BCG therapy in non-muscle-invasive urothelial bladder cancer].
Krajewski, Wojciech
[Genetic and immunologic determinants of intravesical BCG therapy in non-muscle-invasive urothelial bladder cancer]. [electronic resource] - Postepy higieny i medycyny doswiadczalnej (Online) Mar 2014 - 291-300 p. digital
Publication Type: Journal Article; Review
1732-2693
10.5604/17322693.1094714 doi
Administration, Intravesical
Antineoplastic Agents--therapeutic use
BCG Vaccine--immunology
Biomarkers, Tumor--urine
Cytokines--biosynthesis
Humans
Immunotherapy
Interleukin-10--urine
Interleukin-2--urine
Neoplasm Recurrence, Local--prevention & control
Survival Rate
Treatment Outcome
Tumor Necrosis Factor-alpha--urine
Urinary Bladder Neoplasms--drug therapy
[Genetic and immunologic determinants of intravesical BCG therapy in non-muscle-invasive urothelial bladder cancer]. [electronic resource] - Postepy higieny i medycyny doswiadczalnej (Online) Mar 2014 - 291-300 p. digital
Publication Type: Journal Article; Review
1732-2693
10.5604/17322693.1094714 doi
Administration, Intravesical
Antineoplastic Agents--therapeutic use
BCG Vaccine--immunology
Biomarkers, Tumor--urine
Cytokines--biosynthesis
Humans
Immunotherapy
Interleukin-10--urine
Interleukin-2--urine
Neoplasm Recurrence, Local--prevention & control
Survival Rate
Treatment Outcome
Tumor Necrosis Factor-alpha--urine
Urinary Bladder Neoplasms--drug therapy